{ "cik": 1728117, "cik_padded": "0001728117", "entityName": "Gossamer Bio, Inc.", "fiscal_years": [ { "accn": "0001728117-26-000017", "filed": "2026-03-17", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 79000.0, "cash": 37732000.0, "eps_diluted": -0.75, "free_cash_flow": -171345000.0, "net_income": -170370000.0, "operating_cash_flow": -171266000.0, "operating_income": -170728000.0, "revenue": 48471000.0, "stockholders_equity": -122760000.0, "total_assets": 172249000.0, "total_liabilities": 295009000.0 }, "period_end": "2025-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": -0.5774143207121124, "roa_avg2y": -0.6988950672866487, "roa_period_end": -0.9890913735348247, "roe_avg2y": 3.653343054423811 } }, { "accn": "0001728117-26-000017", "filed": "2026-03-17", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 46074000.0, "eps_diluted": -0.25, "free_cash_flow": -3468000.0, "net_income": -56528000.0, "operating_cash_flow": -3468000.0, "operating_income": -59919000.0, "revenue": 114701000.0, "stockholders_equity": 29492000.0, "total_assets": 315292000.0, "total_liabilities": 285800000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 9.690763596907637, "net_margin": -0.4928291819600526, "operating_margin": -0.5223930044201881, "roa_avg2y": -0.18025280289792223, "roa_period_end": -0.17928777133577764, "roe_avg2y": -1.22539317804923, "roe_period_end": -1.916723179167232 } }, { "accn": "0001728117-26-000017", "filed": "2026-03-17", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 32109000.0, "eps_diluted": -1.18, "free_cash_flow": -159158000.0, "net_income": -179817000.0, "operating_cash_flow": -159158000.0, "operating_income": -183759000.0, "stockholders_equity": 62769000.0, "total_assets": 311916000.0, "total_liabilities": 249147000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.969268269368637, "roa_avg2y": -0.6154259488060565, "roa_period_end": -0.576491747778248, "roe_avg2y": -4.804986238409534, "roe_period_end": -2.8647421497873156 } }, { "accn": "0001728117-26-000017", "filed": "2026-03-17", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 410000.0, "cash": 111973000.0, "eps_diluted": -2.71, "free_cash_flow": -187442000.0, "net_income": -229378000.0, "operating_cash_flow": -187032000.0, "operating_income": -218593000.0, "stockholders_equity": 12077000.0, "total_assets": 272450000.0, "total_liabilities": 260373000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "leverage": 21.55941044961497, "roa_avg2y": -0.7446044274776946, "roa_period_end": -0.8419086070838686, "roe_avg2y": -3.435345214916879 } }, { "accn": "0001728117-25-000021", "filed": "2025-03-13", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1546000.0, "cash": 183403000.0, "eps_diluted": -3.13, "free_cash_flow": -190436000.0, "net_income": -234004000.0, "operating_cash_flow": -188890000.0, "operating_income": -216124000.0, "stockholders_equity": 121463000.0, "total_assets": 343657000.0, "total_liabilities": 222194000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.8293142767756436, "roa_avg2y": -0.5299663680938522, "roa_period_end": -0.6809231297485574, "roe_avg2y": -1.0584895973511073, "roe_period_end": -1.9265455323843474 } }, { "accn": "0001728117-24-000019", "filed": "2024-03-05", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1503000.0, "cash": 486055000.0, "eps_diluted": -3.55, "free_cash_flow": -177863000.0, "net_income": -243360000.0, "operating_cash_flow": -176360000.0, "operating_income": -233962000.0, "stockholders_equity": 320684000.0, "total_assets": 539433000.0, "total_liabilities": 218749000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6821325666388095, "roa_avg2y": -0.5038316337780023, "roa_period_end": -0.45114036404891805, "roe_avg2y": -0.7230279469197185, "roe_period_end": -0.7588778984919735 } }, { "accn": "0001728117-23-000010", "filed": "2023-03-17", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2966000.0, "cash": 135026000.0, "eps_diluted": -3.29, "free_cash_flow": -147800000.0, "net_income": -180307000.0, "operating_cash_flow": -144834000.0, "operating_income": -186139000.0, "stockholders_equity": 352485000.0, "total_assets": 426604000.0, "total_liabilities": 74119000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2102756145651588, "roa_avg2y": -0.5414437639540977, "roa_period_end": -0.42265660893943796, "roe_avg2y": -1.5515885309100923, "roe_period_end": -0.5115309871342043 } }, { "accn": "0001728117-22-000019", "filed": "2022-03-03", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3490000.0, "cash": 105219000.0, "free_cash_flow": -54534000.0, "net_income": -146969000.0, "operating_cash_flow": -51044000.0, "operating_income": -148993000.0, "stockholders_equity": -120069000.0, "total_assets": 239419000.0, "total_liabilities": 21121000.0 }, "period_end": "2018-12-31", "ratio_units": { "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_period_end": -0.6138568785267668, "roe_avg2y": 2.3157305937871757 } }, { "accn": "0001728117-21-000019", "filed": "2021-02-26", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD" }, "fundamentals": { "net_income": -6771000.0, "operating_cash_flow": -5745000.0, "operating_income": -6653000.0, "stockholders_equity": -6862000.0 }, "period_end": "2017-12-31", "ratio_units": { "roe_avg2y": "ratio" }, "ratios": { "roe_avg2y": 1.938725841088046 } }, { "accn": "0001564590-20-012323", "filed": "2020-03-24", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": -123000.0 }, "period_end": "2016-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001728117-26-000017", "filed": "2026-03-17", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001728117.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001728117.json" }, "ticker": "GOSS" }